Cryo-Save Group N.V. : Cryo-Save Group N.V. - Share buyback tranche successfully completed

     Cryo-Save Group N.V. : Cryo-Save Group N.V. - Share buyback tranche
                            successfully completed

Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the
leading international stem cell storage company and the largest family stem
cell bank in Europe, announces that it has completed the tranche of its share
buyback programme as announced on 30 January 2013.

The Group has purchased 1,597 shares and has reached an agreement with a
shareholder regarding the buyback of 120,000 shares via its bank Kempen & Co.
The share purchase and the block trade are part of the share buyback programme
as announced yesterday. Cryo-Save repurchased these 121,597 shares at an
average price of € 2.34.

These shares together with the 364,000 treasury shares that are already in the
possession of the Group, representing 5% of the issued shares, will be
proposed for cancellation by the Board at the upcoming Annual General Meeting
on 15 May 2013.

Enquiries:

Cryo-Save Group, Arnoud van Tulder, Chief Executive Officer + 31 (0) 575 509
100
Please click here for full press release in PDF

------------------------------------------------------------------------------

This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
the
information contained therein.

Source: Cryo-Save Group N.V. via Thomson Reuters ONE
HUG#1674596
 
Press spacebar to pause and continue. Press esc to stop.